Malaria is a life-threatening disease that is transmitted
through the bite of infected anopheles mosquitos. The infected mosquitos
transmit the plasmodium parasite into the bloodstream of human body upon being
bitten. As the parasite enters the human body, it travels around the body to
affect the liver and matures with time. Upon attaining maturity, the parasite
enters the bloodstream to infect the red blood cells in the body. This causes
individuals suffering from malaria to frequently experience headache, vomiting,
fever, and weakness.
The Africa
malaria diagnosis & treatment market Research report is projected to
reach USD 2,467.6 Million by 2030 at 6.9% CAGR during the forecast period
2022-2030.It is reported in a study released by Market Research Future (MRFR),
that the market is positively influenced by a number of factors. A major factor
influencing this growth is the increasing advancements in technology related to
diagnostic tools and the proliferating demand for such treatments in
malaria-endemic countries. Other factors driving the market growth are rising
support from the government in terms of investment funds and an increase in the
collaboration between the research centers and the industry. Malaria diagnostic
tests play a significant role in identifying malarial cases, which thereby
boosts the growth of the overall malaria diagnostic market.
However, the lack of precise monitoring standards at
developing nations, acts as a major factor constraining the market. The lack of
awareness among emerging nations and work regulatory framework is of particular
concern for both manufacturers and healthcare providers.
Market Segmentation
The global malaria diagnostics market segmentation is done
as per technology and end-user.
By technology, the market is divided into microscopy,
molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the
molecular diagnostic test is narrowed down into real-time polymerase chain
reaction (RT-PCR) and polymerase chain reaction (PCR).
By end-users, the market comprises of clinics, hospitals,
community healthcare, and others.
Regional Analysis
Geographically, the global malaria diagnostic market covers
regions such as North America, European, Asia Pacific, and Middle East &
Africa.
The North American region holds the largest share of the
malaria diagnostic market and leads the global standings. The region is further
expected to garner the largest market share during the forecast period 2018 and
2023. The market is slated for growth due to the rise in awareness, advancing
medical technologies, favorable compensation setting for various surgical
methods and procedures, medical tourism, and expanding growth of the healthcare
sector.
Competitive Landscape
The global malaria
diagnostics market Trends comprises of a number of key and prominent
players, including Leica Microsystems GmbH, Premier Medical Corporation Pvt.
Ltd, Access Bio. Inc., Beckman Coulter Inc., bioMérieux, Nikon Corporation,
Abbott Laboratories, Olympus Corporation, Sysmex Partec GmbH, Siemens
Healthineers, and Bio-Rad Laboratories Inc.
March 28th, 2019, Global Health Innovative
Technology Fund announced a total of 2.86 Billion Yen to aid 10 partnerships to
research and develop new lifesaving drugs, diagnosis, and vaccines for
disorders like Vaccines for Leishmaniasis and Malaria, Schistosomiasis,
Malaria, Tuberculosis, Dengue, and Diagnostics.
Jan 2nd, 2019, ERADA Technology Alliance LTD, one
of the leaders of innovative, rapid diagnostic solutions for early stage
detection of infectious diseases, announced the launch of one of the world’s
first diagnostic saliva test for malaria.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The Wall